B cells

Antibodies

Breakthrough in COVID-19 Vaccine Development: University of Science and Technology of China Research

Research from the University of Science and Technology of China has led to the development of self-adjuvant-effect biomimetic nanovaccines capable of counteracting current and prospective viral variants of SARS-CoV-2. This innovative approach utilizes synthetic biology technology to create nanoparticles that significantly promote the recruitment of dendritic cells to secondary lymphoid

B cells

Actuate Therapeutics Announces Completion of Phase 1 Study of Elraglusib in Pediatric Patients, Showing Encouraging Results

Actuate Therapeutics, a clinical-stage biopharmaceutical company, has announced the completion of the Phase 1 portion of its clinical study evaluating elraglusib monotherapy or in combination with other treatments in pediatric patients with refractory malignancies. The study, which enrolled ten patients with relapsed/refractory Ewing Sarcoma, has yielded promising results, with